Fortis Healthcare Limited announced its Q1FY21 results on Aug 14, 2020. Consolidated net revenue of Fortis Healthcare Limited in Q1FY21 stood at Rs605.95cr, which declined by 46.77% yoy from Rs1,138.31cr in Q1FY20.
The compny posted negative EBITDA of Rs103.29cr in Q1FY21 that decreased by 172.6% yoy. For Q1FY20, it had posted positive EBITDA of Rs142.28cr. EBITDA margin as of Q1FY21 was at negative 17.05% that declined by 29.55% yoy against the same quarter, the previous year.
The consolidated net loss in Q1FY21 came in at Rs187.88cr which declined by 340.84%, as compared to Q1FY20, when it had reported profit of Rs78.01cr. The net profit margin in Q1FY21 came in at negative 31.01% which declined by 37.86% yoy. The net profit margin for Q1FY20 was at 6.85%.
Share price of company closed at Rs135.8 up by 2.41% on BSE.
|
Particulars |
Q1FY21 (Rs in cr) |
Q1FY20 (Rs in cr) |
% VAR |
|
Net Revenue |
605.95 |
1,138.31 |
-46.77 |
|
Operating Profit(Loss) |
(103.29) |
142.28 |
-172.60 |
|
Net Profit(Loss) |
(187.88) |
78.01 |
-340.84 |
|
EBITDAM% |
-17.05 |
12.50 |
-29.55 |
|
PATM% |
-31.01 |
6.85 |
-37.86 |
Related Tags:
